123 related articles for article (PubMed ID: 413732)
1. Trypanosoma cruzi: nifurtimox's effect on infectivity.
Cardoni RL; Rimoldi MT; de Bracco MM
Exp Parasitol; 1977 Dec; 43(2):370-5. PubMed ID: 413732
[No Abstract] [Full Text] [Related]
2. [Etiological treatment of Chagas' disease].
Rassi A
Arq Bras Cardiol; 1982 Apr; 38(4):277-81. PubMed ID: 6820273
[No Abstract] [Full Text] [Related]
3. [Etiologic therapy of Chagas' disease].
Boainain E; Rassi A
Arq Bras Cardiol; 1979 Jun; 32(6):395-9. PubMed ID: 116629
[No Abstract] [Full Text] [Related]
4. The effect of lampit on Trypanosoma cruzi in mice organs and in the bloodstream.
Villalta F; de Souza W; Leon W
Z Parasitenkd; 1979; 61(1):21-7. PubMed ID: 120645
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Chagas' disease].
Apt W
Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
[No Abstract] [Full Text] [Related]
6. Suppression of antibody dependent cytotoxicity to Trypanosoma cruzi in chronic chagasic mice after treatment with nifurtimox.
Chambó JG; Cabeza Meckert PM; Laguens RP
Medicina (B Aires); 1988; 48(1):49-53. PubMed ID: 3146009
[No Abstract] [Full Text] [Related]
7. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents.
Filardi LS; Brener Z
Mem Inst Oswaldo Cruz; 1984; 79(2):221-5. PubMed ID: 6443014
[TBL] [Abstract][Full Text] [Related]
8. Differences in resistance to reinfection with low and high inocula of Trypanosoma cruzi in chagasic mice treated with nifurtimox and relation to immune response.
Cabeza Meckert P; Chambó JG; Laguens RP
Antimicrob Agents Chemother; 1988 Feb; 32(2):241-5. PubMed ID: 3129986
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of nifurtimox toxicity in different forms of Trypanosoma cruzi.
Docampo R; Moreno SN; Stoppani AO; Leon W; Cruz FS; Villalta F; Muniz RF
Biochem Pharmacol; 1981 Jul; 30(14):1947-51. PubMed ID: 7023488
[No Abstract] [Full Text] [Related]
10. Lipid alterations induced by nifurtimox in Trypanosoma cruzi.
Barreto-Bergter E; Hogge L; Steele da Cruz F
Mol Biochem Parasitol; 1986 Dec; 21(3):221-6. PubMed ID: 3543670
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
Filardi LS; Brener Z
Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
[TBL] [Abstract][Full Text] [Related]
12. Buthionine sulfoximine has anti-Trypanosoma cruzi activity in a murine model of acute Chagas' disease and enhances the efficacy of nifurtimox.
Faúndez M; López-Muñoz R; Torres G; Morello A; Ferreira J; Kemmerling U; Orellana M; Maya JD
Antimicrob Agents Chemother; 2008 May; 52(5):1837-9. PubMed ID: 18332173
[TBL] [Abstract][Full Text] [Related]
13. [Nifurtimox, a bright future for treatment of Chagas disease].
Wolf A; Boulliat C; Coillot C; Rouault M; Gaillard K; Beranger C; Oliver M
Med Trop (Mars); 2011 Apr; 71(2):131-3. PubMed ID: 21695868
[TBL] [Abstract][Full Text] [Related]
14. Activity against Trypanosoma cruzi of new analogues of nifurtimox.
Mester B; Elguero J; Claramunt RM; Castanys S; Mascaró ML; Osuna A; Vilaplana MJ; Molina P
Arch Pharm (Weinheim); 1987 Feb; 320(2):115-20. PubMed ID: 3555404
[No Abstract] [Full Text] [Related]
15. [Mechanism of the trypanocidal action of nifurtimox and other nitro-derivatives on Trypanosoma cruzi].
Docampo R; Stoppani AO
Medicina (B Aires); 1980; 40 Suppl 1():10-6. PubMed ID: 6779074
[No Abstract] [Full Text] [Related]
16. Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi.
Docampo R; Stoppani AO
Arch Biochem Biophys; 1979 Oct; 197(1):317-21. PubMed ID: 232403
[No Abstract] [Full Text] [Related]
17. Cell-mediated immunity in Chagas' disease: Alterations induced by treatment with a trypanocidal drug (nifurtimox).
Lelchuk R; Cardoni RL; Fuks AS
Clin Exp Immunol; 1977 Dec; 30(3):434-8. PubMed ID: 414867
[TBL] [Abstract][Full Text] [Related]
18. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
[TBL] [Abstract][Full Text] [Related]
19. Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil.
Neal RA; van Bueren J; McCoy NG; Iwobi M
Trans R Soc Trop Med Hyg; 1989; 83(2):197-8. PubMed ID: 2558433
[TBL] [Abstract][Full Text] [Related]
20. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
